| CODEXIS INC. DL-,01 |
| USA |
| Gesundheit |
| US1920051067 / A0Q2S4 |
| 4QK (Frankfurt) / CDXS (NASDAQ) |
| FRA:4QK, ETR:4QK, 4QK:GR, NASDAQ:CDXS |
| - |
| http://www.codexis.com/ |
|
Codexis Inc. operates within the biotechnology sector, specializing in the engineering of enzymes and proteins to serve diverse industries. The company's primary function is to harness its proprietary..
>Volltext.. |
| 97.25 Mio. EUR |
| 105.31 Mio. EUR |
| 45.59 Mio. EUR |
| -44.41 Mio. EUR |
| -55.08 Mio. EUR |
| -0.65 EUR |
| 59.11 Mio. EUR |
| 22.25 Mio. EUR |
| -48.18 Mio. EUR |
| 3.2 |
| -22.07% |
| 2.27% |
| - |
| - |
| - |
| CODEXIS |
| 12.03.26 |
|
||||
|